Europe Cervical Cancer Test Market: By Test Type (Colposcopy, Pap smear tests, Endocervical curettage, Human Papilloma Virus (HPV) testing, Visual Inspection with Acetic acid (VIA) testing, Others), By End User (Hospitals, Oncology centers, Diagnostic Centres) and By Country  

Purchase Option

$ 3100
$ 4600
$ 8900

Europe Cervical Cancer Test Market size was valued at USD 1,388.6 million in 2022 and is poised to grow at a CAGR of 4.7% from 2023-2029. Europe market is growing at a significant CAGR owing to technological advancements in cervical cancer diagnostic equipment and procedures. Changes in lifestyles such as smoking, unsafe sex, and high adoption of technologically advanced diagnostic tests are anticipated to fuel the European cervical cancer test market. Moreover, government initiatives for creating awareness about cervical cancer diagnostic tests and an increase in R&D investment for the innovation of novel technologies are also expected to propel the European cervical cancer test market over the forecast period.

However, an increase in the prevalence of cervical cancer in Europe region expected to drive the Europe market. For instance, according to the International Agency for Research on Cancer 2012, the incidence rate of cervical cancer is 13.4 per 100,000 people and the mortality rate is 4.9 per 100,000 people. However, mortality is decreasing owing to an increase in technological advancements in disease diagnostics and the launching of low-cost tests such as the Visual Inspection with Acetic acid (VIA) test. Moreover, acquisitions mergers, and diversification of business segments are the strategies followed by the market players to increase their revenue in Europe's cervical cancer test market. For instance, in July 2011, Roche acquired mtm Laboratories AG for the expansion of the Cervical Cancer Test Market in the Europe region. According to the World Health Organization Europe, approximately 28,000 women die from cervical cancer every year in the Europe region. The prevalence rate is higher in Germany, France, and the U.K. (according to Cancer Research UK 2014, about 3,224 new cervical cancer cases were diagnosed in the U.K.). 

Europe Cervical Cancer Tests Market Dynamics

Cervical cancer is the disease caused by abnormal growth of the cervical cells in the cervix. Cervical cancer is most commonly occurs in women owing to genital Human Papilloma Virus (HPV) infection. It is the most common type of cancer in women and the symptoms in early stages are very low, however, the vaginal bleeding after menopause and pelvic pain are the symptoms shown in a later stage. Cervical cancer can be diagnosed by HPV testing, Pap smear testing, and colposcopy among others.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Europe Cervical Cancer Tests Market Segmentation

By Test Type
  • Colposcopy
  • Pap smear tests
  • Endocervical curettage
  • Human Papilloma Virus (HPV) testing
  • Visual Inspection with Acetic acid (VIA) testing
  • Others
By End User
  • Hospitals
  • Oncology centres
  • Diagnostic Centres

Frequently Asked Questions

The europe cervical cancer test market size was valued at USD 1,388.6 million in 2022

F. Hoffmann La Roche Ltd. (Switzerland) Abbott Diagnostics (U.S.) Oncognostics GmbH (Germany) Becton, Dickinson and Company (U.S.) Randox Laboratories Ltd. (U.K.) Epigenomics AG (Germany) Beckman Coulter (U.S.) Fujirebio Diagnostics, Inc. (U.S.)

1.Executive Summary
2. Europe Cervical Cancer Tests Market Introduction 
2.1. Europe Cervical Cancer Tests Market  - Taxonomy
2.2. Europe Cervical Cancer Tests Market  - Definitions
2.2.1. By Test Type 
2.2.2. By End User
2.2.3. By Country
3. Europe Cervical Cancer Tests Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Europe Cervical Cancer Tests Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Europe Cervical Cancer Tests Market  By Test Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Colposcopy
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Pap smear tests
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Endocervical curettage
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Human Papilloma Virus (HPV) testing
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Visual Inspection with Acetic acid (VIA) testing
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Europe Cervical Cancer Tests Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Oncology centres
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Diagnostic Centres
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Europe Cervical Cancer Tests Market  By Country, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Germany
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. France
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Italy
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. United Kingdom (UK)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Spain
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Germany Cervical Cancer Tests Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Test Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Colposcopy
8.1.2.Pap smear tests
8.1.3.Endocervical curettage
8.1.4.Human Papilloma Virus (HPV) testing
8.1.5.Visual Inspection with Acetic acid (VIA) testing
8.1.6.Others
8.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Oncology centres
8.2.3.Diagnostic Centres
9.France Cervical Cancer Tests Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Test Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Colposcopy
9.1.2.Pap smear tests
9.1.3.Endocervical curettage
9.1.4.Human Papilloma Virus (HPV) testing
9.1.5.Visual Inspection with Acetic acid (VIA) testing
9.1.6.Others
9.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Oncology centres
9.2.3.Diagnostic Centres
10.Italy Cervical Cancer Tests Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Test Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Colposcopy
10.1.2.Pap smear tests
10.1.3.Endocervical curettage
10.1.4.Human Papilloma Virus (HPV) testing
10.1.5.Visual Inspection with Acetic acid (VIA) testing
10.1.6.Others
10.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Oncology centres
10.2.3.Diagnostic Centres
11.United Kingdom (UK) Cervical Cancer Tests Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Test Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Colposcopy
11.1.2.Pap smear tests
11.1.3.Endocervical curettage
11.1.4.Human Papilloma Virus (HPV) testing
11.1.5.Visual Inspection with Acetic acid (VIA) testing
11.1.6.Others
11.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Oncology centres
11.2.3.Diagnostic Centres
12.Spain Cervical Cancer Tests Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Test Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Colposcopy
12.1.2.Pap smear tests
12.1.3.Endocervical curettage
12.1.4.Human Papilloma Virus (HPV) testing
12.1.5.Visual Inspection with Acetic acid (VIA) testing
12.1.6.Others
12.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Oncology centres
12.2.3.Diagnostic Centres
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Leica Microsystems (Germany)
13.2.2.Thermo Fisher Scientific, Inc. (U.S.).
13.2.3.Carl Zeiss AG (Germany)
13.2.4.Molecular Devices, LCC (U.S.)
13.2.5.Nikon Corporation (Japan)
13.2.6.PerkinElmer, Inc. (U.S.)
13.2.7.GE Healthcare (U.K.)
13.2.8.Sigma-Aldrich Corporation (U.S.)
13.2.9.Olympus Corporation (Japan)
14. Research Methodology 
15. Appendix and Abbreviations 
  • F. Hoffmann La Roche Ltd. (Switzerland)
  • Abbott Diagnostics (U.S.)
  • Oncognostics GmbH (Germany)
  • Becton, Dickinson and Company (U.S.)
  • Randox Laboratories Ltd. (U.K.)
  • Epigenomics AG (Germany)
  • Beckman Coulter (U.S.)
  • Fujirebio Diagnostics, Inc. (U.S.)

Adjacent Markets